Building support for the Allergy and Asthma Patient Protection Act
ACAAI’s Advocacy Council is excited to announce a key partnership with Congressman Bob Onder, MD, FACAAI (R-MO-3).
CMS issues standards for electronic exchange of medical records
The rule is intended to replace manual documentation processes — such as faxing, mailing, and payer specific portals — with standardized electronic transaction…
CMS proposes expanding prior authorization regulations to drugs
CMS is proposing an important expansion of its 2024 final rule that establishes an electronic prior authorization process to include drugs covered under a medi…
Understanding Medicare’s Medically Unlikely Edits
Allergists should be aware of the following MUEs associated with commonly billed CPT codes and the following MUE Adjudication Indicators.
Coding conundrum – billing options if vials must be remixed
The Advocacy Council regularly receives queries from members on how to correctly code specific scenarios. Here is a recent request.
Reimbursement challenges for allergy/immunotherapy services remain a problem
ACAAI’s Advocacy Council has made addressing these issues a top priority through our Payer Education Campaign and related initiatives
2026 HIPAA updates
This update provides members with a high-level overview with specific considerations for allergy and immunology practices.
Advocacy Council fights for you on Capitol Hill
Members of the ACAAI Advocacy Council were on Capitol Hill fighting for issues important to allergy practices last week.
New proposed Medicare drug pricing models are unveiled
The College emphasizes that while fair pricing is essential, policies mustn't compromise drug availability or stifle research into new therapies.
… results in College Insider and Advocacy Resources.
